EUVIMEDDescobrir EUVIMED
Open access

Screening Performance of the DSM ‐5 Level 1 Cross‐Cutting Symptom Measure to Detect Psychiatric Comorbidity Among Youth: A Community‐Based Study

João Pedro Gonçalves Pacheco, Christian Kieling iD, João Villanova do Amaral, Pedro H Manfro iD, Ana M B Menezes, Fernando C Barros, Isabel O Oliveira, Fernando C Wehrmeister, Luis Augusto Rohde, Maurício Scopel Hoffmann

Early Intervention in Psychiatry · 2026-07 · 20 (7)

DOI: 10.1111/eip.70201 ↗

At a glance

Journal article in Early Intervention in Psychiatry, published online on 2026-06-25. Written by João Pedro Gonçalves Pacheco and 9 co-authors. Institution: Department of Neuropsychiatry, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. Major MEDLINE topics: Diagnostic and Statistical Manual of Mental Disorders, Mental Disorders, Psychiatric Status Rating Scales. 40 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust, Conselho Nacional de Desenvolvimento Científico e Tecnológico, NIMH NIH HHS.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Introduction

Detection of psychiatric comorbidity is essential given its high burden and frequent under‐recognition. The DSM‐5 Level 1 Cross‐Cutting Symptom Measure (DSM‐XC) is a multidimensional screener designed to capture relevant psychopathological domains, yet its ability to detect comorbid conditions remains unclear. In this study, we evaluated the DSM‐XC's capacity to screen additional psychiatric comorbidity in individuals with an existing psychiatric diagnosis.

Methods

Cross‐sectional data from 796 individuals aged 22 years (60.8% female) from the 1993 Pelotas birth cohort in Brazil were analysed. Participants were included if they met criteria for at least one of seven psychiatric diagnoses based on structured clinical interviews. Screening accuracy metrics were calculated for targeted DSM‐XC domains in identifying secondary diagnoses (e.g., depression domain for major depressive disorder [MDD]), using standard and Youden‐optimized thresholds. Non‐targeted performance assessments (e.g., anxiety domain for MDD) were also performed. Additionally, all 13 domains and the total score were evaluated for detecting any comorbidity.

Results

For the targeted domain assessment, high sensitivity and negative predictive values were observed using original thresholds, supporting rule‐out utility, but specificity and positive likelihood ratios were low. The application of optimized thresholds increased specificity, with positive likelihood ratios reaching ~2 across domains. Non‐targeted domains frequently outperformed targeted domains. Good discrimination for detecting any comorbidity was achieved using the DSM‐XC total score (AUC = 0.75), with a cutoff of ≥ 21 providing the best balance between sensitivity (0.71) and specificity (0.69) and acceptable likelihood ratios.

Conclusions

DSM‐XC domains are useful for excluding comorbidities but have limited confirmatory value. The total score provides a global indicator of comorbidity. These findings support the DSM‐XC primarily as a rule‐out transdiagnostic triage tool for improving comorbidity detection in community settings.

Subjects

MeSH terms (MEDLINE)

Diagnostic and Statistical Manual of Mental DisordersMental DisordersPsychiatric Status Rating ScalesHumansFemaleCross-Sectional StudiesComorbidityBrazilMaleYoung AdultSensitivity and SpecificityMass Screening

Author keywords

DSM‐5DSM‐XCassessmentcross‐disorderpsychiatricquestionnairesscreening

Authors and institutions

  • Department of Neuropsychiatry, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil.
  • Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Mental Health Epidemiology Group (MHEG), Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil.
  • Department of Psychiatry and Legal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Instituto de Pesquisa, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
  • Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.

ORCID profiles: Christian Kieling, Pedro H Manfro

Funding

  • Wellcome Trust
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • NIMH NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Pacheco, J. P. G., Kieling, C., do Amaral, J. V., Manfro, P. H., Menezes, A. M. B., Barros, F. C., Oliveira, I. O., Wehrmeister, F. C., Rohde, L. A., & Hoffmann, M. S. (2026). Screening Performance of the DSM ‐5 Level 1 Cross‐Cutting Symptom Measure to Detect Psychiatric Comorbidity Among Youth: A Community‐Based Study. Early Intervention in Psychiatry, 20(7). https://doi.org/10.1111/eip.70201

Vancouver

Pacheco JPG, Kieling C, do Amaral JV, Manfro PH, Menezes AMB, Barros FC, et al. Screening Performance of the DSM ‐5 Level 1 Cross‐Cutting Symptom Measure to Detect Psychiatric Comorbidity Among Youth: A Community‐Based Study. Early Intervention in Psychiatry. 2026;20(7). doi:10.1111/eip.70201

BibTeX
@article{Pacheco2026,
  author = {Pacheco, João Pedro Gonçalves and Kieling, Christian and do Amaral, João Villanova and Manfro, Pedro H and Menezes, Ana M B and Barros, Fernando C and Oliveira, Isabel O and Wehrmeister, Fernando C and Rohde, Luis Augusto and Hoffmann, Maurício Scopel},
  title = {Screening Performance of the DSM ‐5 Level 1 Cross‐Cutting Symptom Measure to Detect Psychiatric Comorbidity Among Youth: A Community‐Based Study},
  journal = {Early Intervention in Psychiatry},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.1111/eip.70201}
}
Start for free →